Previous 10 | Next 10 |
Palm Beach, FL – June 24, 2021 – According to the Centers for Disease Control and Prevention, Alzheimer’s is among the top 10 leading causes of deaths in the United States. The death rate for the disease has increased significantly in the U.S. over the past few years. M...
San Francisco, California--(Newsfile Corp. - June 22, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now . The firm is investigating possible securities law violations related to Athira's recent decision to plac...
On a generally lousy day for stocks, Athira Pharma (NASDAQ: ATHA) did even worse than many decliners on Friday. The shares fell by almost 39% on the day, on disquieting news about the company's leadership. Athira announced that its COO, Mark Litton, has been tapped to lead the c...
NEW YORK, NY / ACCESSWIRE / June 18, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential securities violations and breach of fiduciary duty claims against Athira Pharma, Inc. (NASDAQ:ATHA). In a brief press release late Thur...
Washington State University to review claims of research misconduct PR Newswire PULLMAN, Wash. , June 18, 2021 /PRNewswire/ -- Washington State University announced today that it has undertaken a review of claims of potential research misconduct involvi...
Gainers: Geron (GERN) +48%.CAI International (CAI) +46%.Sykes Enterprises (SYKE) +30%.PDS Biotechnology (PDSB) +18%.Smith & Wesson Brands (SWBI) +17%.Biophytis (BPTS) +13%.SemiLEDs (LEDS) +10%.Clean Energy Fuels (CLNE) +10%.Luokung Technology (LKCO) +10%.Vinco Ventures (BBIG) +9%.Los...
Gainers: Geron (GERN) +22%, AnPac Bio-Medical Science (ANPC) +20%, CureVac (CVAC) +13%, Crinetics Pharmaceuticals (CRNX) +7%, Seres Therapeutics (MCRB) +7%.Losers: Orphazyme (ORPH) -41%, Athira Pharma (ATHA) -41%, Chinook Therap...
NEW YORK, NY / ACCESSWIRE / June 18, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential securities violations and breach of fiduciary duty claims against Athira Pharma, Inc. (NASDAQ:ATHA). In a brief press release lat...
solarseven/iStock via Getty Images Next year at this time, the markets might be closed for the new Juneteenth federal holiday. For today, though, trading remain open, with Bristol Myers (BMY), CAI International (CAI), Geron (GERN) and Athira Pharma (ATHA) all making news before Friday's open....
Orphazyme (ORPH) -53% on FDA thumbs down for arimoclomol; cuts FY21 outlook.Athira Pharma (ATHA) -30% after the decision to place CEO on temporary leave.Capstone Green Energy (CGRN) -26% on $10M capital raiseCellect Biotechnology (APOP) -9%.Arrival (ARVL) -9...
News, Short Squeeze, Breakout and More Instantly...
Reporting of Topline Results Targeted by End of Third Quarter 2024 Results to be presented in oral presentation at Clinical Trials on Alzheimer’s Disease (CTAD) on October 29, 2024, in Madrid, Spain BOTHELL, Wash., July 09, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc (N...
Company to provide overview of Phase 2/3 LIFT-AD clinical trial of fosgonimeton in mild-to-moderate Alzheimer’s disease (AD); LIFT-AD topline data expected in second half of 2024 Two key opinion leaders will discuss ongoing unmet medical need and LIFT-AD’s primary endpoint...
BOTHELL, Wash., June 11, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that it has completed the first cohort of healthy ...